Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Human Interleukin-2 (IL-2) Market Growth 2022-2028

  • LP 4832681
  • 123 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Human Interleukin-2 (IL-2) will have significant change from previous year. According to our (LP Information) latest study, the global Human Interleukin-2 (IL-2) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Human Interleukin-2 (IL-2) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Human Interleukin-2 (IL-2) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Human Interleukin-2 (IL-2) market, reaching US$ million by the year 2028. As for the Europe Human Interleukin-2 (IL-2) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Human Interleukin-2 (IL-2) players cover Roche, BMS, Schering-Plough, and AbbVie Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Interleukin-2 (IL-2) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

50000 U

100000 U

200000 U

500000 U

1 Million U

2 Million U

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Recombinant Interferon

Recombinant Interleukin

Natural Biological Products

Poison Immune

Gene Therapy

Monoclonal Antibody

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Roche

BMS

Schering-Plough

AbbVie Inc

Alkermes Plc

APT Therapeutics

Mabtech Limited

Philogen

Sinopharm

Jiangsu Jinsili Pharmaceutical

Shenyang Sansheng Pharmaceutical

Beijing Shuanglu Pharmaceutical

Shandong Quangang Pharmaceutical

Shanghai Huaxin Biological high-tech

Beijing Yuance Pharmaceutical

Beijing Sihuan Biological Pharmaceutical

Beijing Sanyuan Gene Pharmaceutical

Shenzhen Kexing Biological Engineering

Shanghai Sanwei Biotechnology

Xiamen Tebao Biological Engineering

Chengdu huashen Biotechnology

Shanghai Pharma Group

Guangdong Xinghao Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Interleukin-2 (IL-2) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Interleukin-2 (IL-2) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Interleukin-2 (IL-2) by Country/Region, 2017, 2022 & 2028

2.2 Human Interleukin-2 (IL-2) Segment by Type

2.2.1 50000 U

2.2.2 100000 U

2.2.3 200000 U

2.2.4 500000 U

2.2.5 1 Million U

2.2.6 2 Million U

2.3 Human Interleukin-2 (IL-2) Sales by Type

2.3.1 Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2017-2022)

2.3.2 Global Human Interleukin-2 (IL-2) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Interleukin-2 (IL-2) Sale Price by Type (2017-2022)

2.4 Human Interleukin-2 (IL-2) Segment by Application

2.4.1 Recombinant Interferon

2.4.2 Recombinant Interleukin

2.4.3 Natural Biological Products

2.4.4 Poison Immune

2.4.5 Gene Therapy

2.4.6 Monoclonal Antibody

2.5 Human Interleukin-2 (IL-2) Sales by Application

2.5.1 Global Human Interleukin-2 (IL-2) Sale Market Share by Application (2017-2022)

2.5.2 Global Human Interleukin-2 (IL-2) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Interleukin-2 (IL-2) Sale Price by Application (2017-2022)

3 Global Human Interleukin-2 (IL-2) by Company

3.1 Global Human Interleukin-2 (IL-2) Breakdown Data by Company

3.1.1 Global Human Interleukin-2 (IL-2) Annual Sales by Company (2020-2022)

3.1.2 Global Human Interleukin-2 (IL-2) Sales Market Share by Company (2020-2022)

3.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Company (2020-2022)

3.2.1 Global Human Interleukin-2 (IL-2) Revenue by Company (2020-2022)

3.2.2 Global Human Interleukin-2 (IL-2) Revenue Market Share by Company (2020-2022)

3.3 Global Human Interleukin-2 (IL-2) Sale Price by Company

3.4 Key Manufacturers Human Interleukin-2 (IL-2) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Interleukin-2 (IL-2) Product Location Distribution

3.4.2 Players Human Interleukin-2 (IL-2) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Interleukin-2 (IL-2) by Geographic Region

4.1 World Historic Human Interleukin-2 (IL-2) Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Interleukin-2 (IL-2) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Geographic Region

4.2 World Historic Human Interleukin-2 (IL-2) Market Size by Country/Region (2017-2022)

4.2.1 Global Human Interleukin-2 (IL-2) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Interleukin-2 (IL-2) Annual Revenue by Country/Region

4.3 Americas Human Interleukin-2 (IL-2) Sales Growth

4.4 APAC Human Interleukin-2 (IL-2) Sales Growth

4.5 Europe Human Interleukin-2 (IL-2) Sales Growth

4.6 Middle East & Africa Human Interleukin-2 (IL-2) Sales Growth

5 Americas

5.1 Americas Human Interleukin-2 (IL-2) Sales by Country

5.1.1 Americas Human Interleukin-2 (IL-2) Sales by Country (2017-2022)

5.1.2 Americas Human Interleukin-2 (IL-2) Revenue by Country (2017-2022)

5.2 Americas Human Interleukin-2 (IL-2) Sales by Type

5.3 Americas Human Interleukin-2 (IL-2) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Interleukin-2 (IL-2) Sales by Region

6.1.1 APAC Human Interleukin-2 (IL-2) Sales by Region (2017-2022)

6.1.2 APAC Human Interleukin-2 (IL-2) Revenue by Region (2017-2022)

6.2 APAC Human Interleukin-2 (IL-2) Sales by Type

6.3 APAC Human Interleukin-2 (IL-2) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Interleukin-2 (IL-2) by Country

7.1.1 Europe Human Interleukin-2 (IL-2) Sales by Country (2017-2022)

7.1.2 Europe Human Interleukin-2 (IL-2) Revenue by Country (2017-2022)

7.2 Europe Human Interleukin-2 (IL-2) Sales by Type

7.3 Europe Human Interleukin-2 (IL-2) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Interleukin-2 (IL-2) by Country

8.1.1 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Type

8.3 Middle East & Africa Human Interleukin-2 (IL-2) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Interleukin-2 (IL-2)

10.3 Manufacturing Process Analysis of Human Interleukin-2 (IL-2)

10.4 Industry Chain Structure of Human Interleukin-2 (IL-2)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Interleukin-2 (IL-2) Distributors

11.3 Human Interleukin-2 (IL-2) Customer

12 World Forecast Review for Human Interleukin-2 (IL-2) by Geographic Region

12.1 Global Human Interleukin-2 (IL-2) Market Size Forecast by Region

12.1.1 Global Human Interleukin-2 (IL-2) Forecast by Region (2023-2028)

12.1.2 Global Human Interleukin-2 (IL-2) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Interleukin-2 (IL-2) Forecast by Type

12.7 Global Human Interleukin-2 (IL-2) Forecast by Application

13 Key Players Analysis

13.1 Roche

13.1.1 Roche Company Information

13.1.2 Roche Human Interleukin-2 (IL-2) Product Offered

13.1.3 Roche Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Roche Main Business Overview

13.1.5 Roche Latest Developments

13.2 BMS

13.2.1 BMS Company Information

13.2.2 BMS Human Interleukin-2 (IL-2) Product Offered

13.2.3 BMS Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BMS Main Business Overview

13.2.5 BMS Latest Developments

13.3 Schering-Plough

13.3.1 Schering-Plough Company Information

13.3.2 Schering-Plough Human Interleukin-2 (IL-2) Product Offered

13.3.3 Schering-Plough Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Schering-Plough Main Business Overview

13.3.5 Schering-Plough Latest Developments

13.4 AbbVie Inc

13.4.1 AbbVie Inc Company Information

13.4.2 AbbVie Inc Human Interleukin-2 (IL-2) Product Offered

13.4.3 AbbVie Inc Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AbbVie Inc Main Business Overview

13.4.5 AbbVie Inc Latest Developments

13.5 Alkermes Plc

13.5.1 Alkermes Plc Company Information

13.5.2 Alkermes Plc Human Interleukin-2 (IL-2) Product Offered

13.5.3 Alkermes Plc Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Alkermes Plc Main Business Overview

13.5.5 Alkermes Plc Latest Developments

13.6 APT Therapeutics

13.6.1 APT Therapeutics Company Information

13.6.2 APT Therapeutics Human Interleukin-2 (IL-2) Product Offered

13.6.3 APT Therapeutics Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 APT Therapeutics Main Business Overview

13.6.5 APT Therapeutics Latest Developments

13.7 Mabtech Limited

13.7.1 Mabtech Limited Company Information

13.7.2 Mabtech Limited Human Interleukin-2 (IL-2) Product Offered

13.7.3 Mabtech Limited Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mabtech Limited Main Business Overview

13.7.5 Mabtech Limited Latest Developments

13.8 Philogen

13.8.1 Philogen Company Information

13.8.2 Philogen Human Interleukin-2 (IL-2) Product Offered

13.8.3 Philogen Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Philogen Main Business Overview

13.8.5 Philogen Latest Developments

13.9 Sinopharm

13.9.1 Sinopharm Company Information

13.9.2 Sinopharm Human Interleukin-2 (IL-2) Product Offered

13.9.3 Sinopharm Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sinopharm Main Business Overview

13.9.5 Sinopharm Latest Developments

13.10 Jiangsu Jinsili Pharmaceutical

13.10.1 Jiangsu Jinsili Pharmaceutical Company Information

13.10.2 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

13.10.3 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Jiangsu Jinsili Pharmaceutical Main Business Overview

13.10.5 Jiangsu Jinsili Pharmaceutical Latest Developments

13.11 Shenyang Sansheng Pharmaceutical

13.11.1 Shenyang Sansheng Pharmaceutical Company Information

13.11.2 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

13.11.3 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Shenyang Sansheng Pharmaceutical Main Business Overview

13.11.5 Shenyang Sansheng Pharmaceutical Latest Developments

13.12 Beijing Shuanglu Pharmaceutical

13.12.1 Beijing Shuanglu Pharmaceutical Company Information

13.12.2 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

13.12.3 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Beijing Shuanglu Pharmaceutical Main Business Overview

13.12.5 Beijing Shuanglu Pharmaceutical Latest Developments

13.13 Shandong Quangang Pharmaceutical

13.13.1 Shandong Quangang Pharmaceutical Company Information

13.13.2 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

13.13.3 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shandong Quangang Pharmaceutical Main Business Overview

13.13.5 Shandong Quangang Pharmaceutical Latest Developments

13.14 Shanghai Huaxin Biological high-tech

13.14.1 Shanghai Huaxin Biological high-tech Company Information

13.14.2 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product Offered

13.14.3 Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Shanghai Huaxin Biological high-tech Main Business Overview

13.14.5 Shanghai Huaxin Biological high-tech Latest Developments

13.15 Beijing Yuance Pharmaceutical

13.15.1 Beijing Yuance Pharmaceutical Company Information

13.15.2 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

13.15.3 Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Beijing Yuance Pharmaceutical Main Business Overview

13.15.5 Beijing Yuance Pharmaceutical Latest Developments

13.16 Beijing Sihuan Biological Pharmaceutical

13.16.1 Beijing Sihuan Biological Pharmaceutical Company Information

13.16.2 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

13.16.3 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Beijing Sihuan Biological Pharmaceutical Main Business Overview

13.16.5 Beijing Sihuan Biological Pharmaceutical Latest Developments

13.17 Beijing Sanyuan Gene Pharmaceutical

13.17.1 Beijing Sanyuan Gene Pharmaceutical Company Information

13.17.2 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

13.17.3 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Beijing Sanyuan Gene Pharmaceutical Main Business Overview

13.17.5 Beijing Sanyuan Gene Pharmaceutical Latest Developments

13.18 Shenzhen Kexing Biological Engineering

13.18.1 Shenzhen Kexing Biological Engineering Company Information

13.18.2 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product Offered

13.18.3 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Shenzhen Kexing Biological Engineering Main Business Overview

13.18.5 Shenzhen Kexing Biological Engineering Latest Developments

13.19 Shanghai Sanwei Biotechnology

13.19.1 Shanghai Sanwei Biotechnology Company Information

13.19.2 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product Offered

13.19.3 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Shanghai Sanwei Biotechnology Main Business Overview

13.19.5 Shanghai Sanwei Biotechnology Latest Developments

13.20 Xiamen Tebao Biological Engineering

13.20.1 Xiamen Tebao Biological Engineering Company Information

13.20.2 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product Offered

13.20.3 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Xiamen Tebao Biological Engineering Main Business Overview

13.20.5 Xiamen Tebao Biological Engineering Latest Developments

13.21 Chengdu huashen Biotechnology

13.21.1 Chengdu huashen Biotechnology Company Information

13.21.2 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product Offered

13.21.3 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Chengdu huashen Biotechnology Main Business Overview

13.21.5 Chengdu huashen Biotechnology Latest Developments

13.22 Shanghai Pharma Group

13.22.1 Shanghai Pharma Group Company Information

13.22.2 Shanghai Pharma Group Human Interleukin-2 (IL-2) Product Offered

13.22.3 Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Shanghai Pharma Group Main Business Overview

13.22.5 Shanghai Pharma Group Latest Developments

13.23 Guangdong Xinghao Pharmaceutical

13.23.1 Guangdong Xinghao Pharmaceutical Company Information

13.23.2 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

13.23.3 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Guangdong Xinghao Pharmaceutical Main Business Overview

13.23.5 Guangdong Xinghao Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Human Interleukin-2 (IL-2) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Interleukin-2 (IL-2) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 50000 U

Table 4. Major Players of 100000 U

Table 5. Major Players of 200000 U

Table 6. Major Players of 500000 U

Table 7. Major Players of 1 Million U

Table 8. Major Players of 2 Million U

Table 9. Global Human Interleukin-2 (IL-2) Sales by Type (2017-2022) & (KG)

Table 10. Global Human Interleukin-2 (IL-2) Sales Market Share by Type (2017-2022)

Table 11. Global Human Interleukin-2 (IL-2) Revenue by Type (2017-2022) & ($ million)

Table 12. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2017-2022)

Table 13. Global Human Interleukin-2 (IL-2) Sale Price by Type (2017-2022) & (US$/G)

Table 14. Global Human Interleukin-2 (IL-2) Sales by Application (2017-2022) & (KG)

Table 15. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2017-2022)

Table 16. Global Human Interleukin-2 (IL-2) Revenue by Application (2017-2022)

Table 17. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application (2017-2022)

Table 18. Global Human Interleukin-2 (IL-2) Sale Price by Application (2017-2022) & (US$/G)

Table 19. Global Human Interleukin-2 (IL-2) Sales by Company (2020-2022) & (KG)

Table 20. Global Human Interleukin-2 (IL-2) Sales Market Share by Company (2020-2022)

Table 21. Global Human Interleukin-2 (IL-2) Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company (2020-2022)

Table 23. Global Human Interleukin-2 (IL-2) Sale Price by Company (2020-2022) & (US$/G)

Table 24. Key Manufacturers Human Interleukin-2 (IL-2) Producing Area Distribution and Sales Area

Table 25. Players Human Interleukin-2 (IL-2) Products Offered

Table 26. Human Interleukin-2 (IL-2) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Human Interleukin-2 (IL-2) Sales by Geographic Region (2017-2022) & (KG)

Table 30. Global Human Interleukin-2 (IL-2) Sales Market Share Geographic Region (2017-2022)

Table 31. Global Human Interleukin-2 (IL-2) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Human Interleukin-2 (IL-2) Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Human Interleukin-2 (IL-2) Sales by Country/Region (2017-2022) & (KG)

Table 34. Global Human Interleukin-2 (IL-2) Sales Market Share by Country/Region (2017-2022)

Table 35. Global Human Interleukin-2 (IL-2) Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Human Interleukin-2 (IL-2) Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Human Interleukin-2 (IL-2) Sales by Country (2017-2022) & (KG)

Table 38. Americas Human Interleukin-2 (IL-2) Sales Market Share by Country (2017-2022)

Table 39. Americas Human Interleukin-2 (IL-2) Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Human Interleukin-2 (IL-2) Revenue Market Share by Country (2017-2022)

Table 41. Americas Human Interleukin-2 (IL-2) Sales by Type (2017-2022) & (KG)

Table 42. Americas Human Interleukin-2 (IL-2) Sales Market Share by Type (2017-2022)

Table 43. Americas Human Interleukin-2 (IL-2) Sales by Application (2017-2022) & (KG)

Table 44. Americas Human Interleukin-2 (IL-2) Sales Market Share by Application (2017-2022)

Table 45. APAC Human Interleukin-2 (IL-2) Sales by Region (2017-2022) & (KG)

Table 46. APAC Human Interleukin-2 (IL-2) Sales Market Share by Region (2017-2022)

Table 47. APAC Human Interleukin-2 (IL-2) Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Human Interleukin-2 (IL-2) Revenue Market Share by Region (2017-2022)

Table 49. APAC Human Interleukin-2 (IL-2) Sales by Type (2017-2022) & (KG)

Table 50. APAC Human Interleukin-2 (IL-2) Sales Market Share by Type (2017-2022)

Table 51. APAC Human Interleukin-2 (IL-2) Sales by Application (2017-2022) & (KG)

Table 52. APAC Human Interleukin-2 (IL-2) Sales Market Share by Application (2017-2022)

Table 53. Europe Human Interleukin-2 (IL-2) Sales by Country (2017-2022) & (KG)

Table 54. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country (2017-2022)

Table 55. Europe Human Interleukin-2 (IL-2) Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country (2017-2022)

Table 57. Europe Human Interleukin-2 (IL-2) Sales by Type (2017-2022) & (KG)

Table 58. Europe Human Interleukin-2 (IL-2) Sales Market Share by Type (2017-2022)

Table 59. Europe Human Interleukin-2 (IL-2) Sales by Application (2017-2022) & (KG)

Table 60. Europe Human Interleukin-2 (IL-2) Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Country (2017-2022) & (KG)

Table 62. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Human Interleukin-2 (IL-2) Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Type (2017-2022) & (KG)

Table 66. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Human Interleukin-2 (IL-2) Sales by Application (2017-2022) & (KG)

Table 68. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Human Interleukin-2 (IL-2)

Table 70. Key Market Challenges & Risks of Human Interleukin-2 (IL-2)

Table 71. Key Industry Trends of Human Interleukin-2 (IL-2)

Table 72. Human Interleukin-2 (IL-2) Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Human Interleukin-2 (IL-2) Distributors List

Table 75. Human Interleukin-2 (IL-2) Customer List

Table 76. Global Human Interleukin-2 (IL-2) Sales Forecast by Region (2023-2028) & (KG)

Table 77. Global Human Interleukin-2 (IL-2) Sales Market Forecast by Region

Table 78. Global Human Interleukin-2 (IL-2) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Human Interleukin-2 (IL-2) Sales Forecast by Country (2023-2028) & (KG)

Table 81. Americas Human Interleukin-2 (IL-2) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Human Interleukin-2 (IL-2) Sales Forecast by Region (2023-2028) & (KG)

Table 83. APAC Human Interleukin-2 (IL-2) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Human Interleukin-2 (IL-2) Sales Forecast by Country (2023-2028) & (KG)

Table 85. Europe Human Interleukin-2 (IL-2) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Human Interleukin-2 (IL-2) Sales Forecast by Country (2023-2028) & (KG)

Table 87. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Human Interleukin-2 (IL-2) Sales Forecast by Type (2023-2028) & (KG)

Table 89. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Human Interleukin-2 (IL-2) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Human Interleukin-2 (IL-2) Sales Forecast by Application (2023-2028) & (KG)

Table 93. Global Human Interleukin-2 (IL-2) Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Human Interleukin-2 (IL-2) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Human Interleukin-2 (IL-2) Revenue Market Share Forecast by Application (2023-2028)

Table 96. Roche Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 97. Roche Human Interleukin-2 (IL-2) Product Offered

Table 98. Roche Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 99. Roche Main Business

Table 100. Roche Latest Developments

Table 101. BMS Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 102. BMS Human Interleukin-2 (IL-2) Product Offered

Table 103. BMS Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 104. BMS Main Business

Table 105. BMS Latest Developments

Table 106. Schering-Plough Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 107. Schering-Plough Human Interleukin-2 (IL-2) Product Offered

Table 108. Schering-Plough Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 109. Schering-Plough Main Business

Table 110. Schering-Plough Latest Developments

Table 111. AbbVie Inc Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 112. AbbVie Inc Human Interleukin-2 (IL-2) Product Offered

Table 113. AbbVie Inc Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 114. AbbVie Inc Main Business

Table 115. AbbVie Inc Latest Developments

Table 116. Alkermes Plc Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 117. Alkermes Plc Human Interleukin-2 (IL-2) Product Offered

Table 118. Alkermes Plc Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 119. Alkermes Plc Main Business

Table 120. Alkermes Plc Latest Developments

Table 121. APT Therapeutics Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 122. APT Therapeutics Human Interleukin-2 (IL-2) Product Offered

Table 123. APT Therapeutics Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 124. APT Therapeutics Main Business

Table 125. APT Therapeutics Latest Developments

Table 126. Mabtech Limited Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 127. Mabtech Limited Human Interleukin-2 (IL-2) Product Offered

Table 128. Mabtech Limited Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 129. Mabtech Limited Main Business

Table 130. Mabtech Limited Latest Developments

Table 131. Philogen Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 132. Philogen Human Interleukin-2 (IL-2) Product Offered

Table 133. Philogen Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 134. Philogen Main Business

Table 135. Philogen Latest Developments

Table 136. Sinopharm Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 137. Sinopharm Human Interleukin-2 (IL-2) Product Offered

Table 138. Sinopharm Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 139. Sinopharm Main Business

Table 140. Sinopharm Latest Developments

Table 141. Jiangsu Jinsili Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 142. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

Table 143. Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 144. Jiangsu Jinsili Pharmaceutical Main Business

Table 145. Jiangsu Jinsili Pharmaceutical Latest Developments

Table 146. Shenyang Sansheng Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 147. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

Table 148. Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 149. Shenyang Sansheng Pharmaceutical Main Business

Table 150. Shenyang Sansheng Pharmaceutical Latest Developments

Table 151. Beijing Shuanglu Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 152. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

Table 153. Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 154. Beijing Shuanglu Pharmaceutical Main Business

Table 155. Beijing Shuanglu Pharmaceutical Latest Developments

Table 156. Shandong Quangang Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 157. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

Table 158. Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 159. Shandong Quangang Pharmaceutical Main Business

Table 160. Shandong Quangang Pharmaceutical Latest Developments

Table 161. Shanghai Huaxin Biological high-tech Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 162. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Product Offered

Table 163. Shanghai Huaxin Biological high-tech Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 164. Shanghai Huaxin Biological high-tech Main Business

Table 165. Shanghai Huaxin Biological high-tech Latest Developments

Table 166. Beijing Yuance Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 167. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

Table 168. Beijing Yuance Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 169. Beijing Yuance Pharmaceutical Main Business

Table 170. Beijing Yuance Pharmaceutical Latest Developments

Table 171. Beijing Sihuan Biological Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 172. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

Table 173. Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 174. Beijing Sihuan Biological Pharmaceutical Main Business

Table 175. Beijing Sihuan Biological Pharmaceutical Latest Developments

Table 176. Beijing Sanyuan Gene Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 177. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

Table 178. Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 179. Beijing Sanyuan Gene Pharmaceutical Main Business

Table 180. Beijing Sanyuan Gene Pharmaceutical Latest Developments

Table 181. Shenzhen Kexing Biological Engineering Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 182. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Product Offered

Table 183. Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 184. Shenzhen Kexing Biological Engineering Main Business

Table 185. Shenzhen Kexing Biological Engineering Latest Developments

Table 186. Shanghai Sanwei Biotechnology Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 187. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Product Offered

Table 188. Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 189. Shanghai Sanwei Biotechnology Main Business

Table 190. Shanghai Sanwei Biotechnology Latest Developments

Table 191. Xiamen Tebao Biological Engineering Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 192. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Product Offered

Table 193. Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 194. Xiamen Tebao Biological Engineering Main Business

Table 195. Xiamen Tebao Biological Engineering Latest Developments

Table 196. Chengdu huashen Biotechnology Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 197. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Product Offered

Table 198. Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 199. Chengdu huashen Biotechnology Main Business

Table 200. Chengdu huashen Biotechnology Latest Developments

Table 201. Shanghai Pharma Group Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 202. Shanghai Pharma Group Human Interleukin-2 (IL-2) Product Offered

Table 203. Shanghai Pharma Group Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 204. Shanghai Pharma Group Main Business

Table 205. Shanghai Pharma Group Latest Developments

Table 206. Guangdong Xinghao Pharmaceutical Basic Information, Human Interleukin-2 (IL-2) Manufacturing Base, Sales Area and Its Competitors

Table 207. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Product Offered

Table 208. Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)

Table 209. Guangdong Xinghao Pharmaceutical Main Business

Table 210. Guangdong Xinghao Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Human Interleukin-2 (IL-2)

Figure 2. Human Interleukin-2 (IL-2) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Interleukin-2 (IL-2) Sales Growth Rate 2017-2028 (KG)

Figure 7. Global Human Interleukin-2 (IL-2) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Interleukin-2 (IL-2) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 50000 U

Figure 10. Product Picture of 100000 U

Figure 11. Product Picture of 200000 U

Figure 12. Product Picture of 500000 U

Figure 13. Product Picture of 1 Million U

Figure 14. Product Picture of 2 Million U

Figure 15. Global Human Interleukin-2 (IL-2) Sales Market Share by Type in 2021

Figure 16. Global Human Interleukin-2 (IL-2) Revenue Market Share by Type (2017-2022)

Figure 17. Human Interleukin-2 (IL-2) Consumed in Recombinant Interferon

Figure 18. Global Human Interleukin-2 (IL-2) Market: Recombinant Interferon (2017-2022) & (KG)

Figure 19. Human Interleukin-2 (IL-2) Consumed in Recombinant Interleukin

Figure 20. Global Human Interleukin-2 (IL-2) Market: Recombinant Interleukin (2017-2022) & (KG)

Figure 21. Human Interleukin-2 (IL-2) Consumed in Natural Biological Products

Figure 22. Global Human Interleukin-2 (IL-2) Market: Natural Biological Products (2017-2022) & (KG)

Figure 23. Human Interleukin-2 (IL-2) Consumed in Poison Immune

Figure 24. Global Human Interleukin-2 (IL-2) Market: Poison Immune (2017-2022) & (KG)

Figure 25. Human Interleukin-2 (IL-2) Consumed in Gene Therapy

Figure 26. Global Human Interleukin-2 (IL-2) Market: Gene Therapy (2017-2022) & (KG)

Figure 27. Human Interleukin-2 (IL-2) Consumed in Monoclonal Antibody

Figure 28. Global Human Interleukin-2 (IL-2) Market: Monoclonal Antibody (2017-2022) & (KG)

Figure 29. Global Human Interleukin-2 (IL-2) Sales Market Share by Application (2017-2022)

Figure 30. Global Human Interleukin-2 (IL-2) Revenue Market Share by Application in 2021

Figure 31. Human Interleukin-2 (IL-2) Revenue Market by Company in 2021 ($ Million)

Figure 32. Global Human Interleukin-2 (IL-2) Revenue Market Share by Company in 2021

Figure 33. Global Human Interleukin-2 (IL-2) Sales Market Share by Geographic Region (2017-2022)

Figure 34. Global Human Interleukin-2 (IL-2) Revenue Market Share by Geographic Region in 2021

Figure 35. Global Human Interleukin-2 (IL-2) Sales Market Share by Region (2017-2022)

Figure 36. Global Human Interleukin-2 (IL-2) Revenue Market Share by Country/Region in 2021

Figure 37. Americas Human Interleukin-2 (IL-2) Sales 2017-2022 (KG)

Figure 38. Americas Human Interleukin-2 (IL-2) Revenue 2017-2022 ($ Millions)

Figure 39. APAC Human Interleukin-2 (IL-2) Sales 2017-2022 (KG)

Figure 40. APAC Human Interleukin-2 (IL-2) Revenue 2017-2022 ($ Millions)

Figure 41. Europe Human Interleukin-2 (IL-2) Sales 2017-2022 (KG)

Figure 42. Europe Human Interleukin-2 (IL-2) Revenue 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Human Interleukin-2 (IL-2) Sales 2017-2022 (KG)

Figure 44. Middle East & Africa Human Interleukin-2 (IL-2) Revenue 2017-2022 ($ Millions)

Figure 45. Americas Human Interleukin-2 (IL-2) Sales Market Share by Country in 2021

Figure 46. Americas Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2021

Figure 47. United States Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Canada Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Mexico Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Brazil Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 51. APAC Human Interleukin-2 (IL-2) Sales Market Share by Region in 2021

Figure 52. APAC Human Interleukin-2 (IL-2) Revenue Market Share by Regions in 2021

Figure 53. China Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Japan Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 55. South Korea Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Southeast Asia Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 57. India Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Australia Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 59. Europe Human Interleukin-2 (IL-2) Sales Market Share by Country in 2021

Figure 60. Europe Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2021

Figure 61. Germany Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 62. France Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 63. UK Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Italy Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Russia Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 66. Middle East & Africa Human Interleukin-2 (IL-2) Sales Market Share by Country in 2021

Figure 67. Middle East & Africa Human Interleukin-2 (IL-2) Revenue Market Share by Country in 2021

Figure 68. Egypt Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 69. South Africa Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 70. Israel Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 71. Turkey Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 72. GCC Country Human Interleukin-2 (IL-2) Revenue Growth 2017-2022 ($ Millions)

Figure 73. Manufacturing Cost Structure Analysis of Human Interleukin-2 (IL-2) in 2021

Figure 74. Manufacturing Process Analysis of Human Interleukin-2 (IL-2)

Figure 75. Industry Chain Structure of Human Interleukin-2 (IL-2)

Figure 76. Channels of Distribution

Figure 77. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390